$Aytu BioPharma (AYTU.US)$Revenue has continued to grow over...

$Aytu BioPharma (AYTU.US)$Revenue has continued to grow over the past 5 years, operating profit and net profit losses have continued to expand, revenue continued to grow in the first two quarters of 2023, and operating profit and net profit losses have narrowed drastically. We can observe a few more quarters before making a judgment.